You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
【瑞通认股证牛熊证】石药未止跌见一个月低位 银娱向上挑战250天线 石药购25482 沽28344/ 银河牛61488 熊60495/ 美团最贴牛61724 熊57595
阿思达克 12-02 10:13

市场忧虑中美关系再次紧张,道指上周五收报28051点,跌112点(或0.4%),全月计则累升3.7%。中国11月官方制造业PMI升上50.2,胜市场预期。

恒指上周五收报26346点,挫547点(或2%),整个11月亦累跌2%。今早一度回升过百点,高位触及26500点水平,其後升幅曾收窄。恒指好仓(牛证及认购权证)上周五净流入逾1.6亿港元(下同),恒指淡仓(熊证及认沽权证)同日净流出逾1.7亿元,反映投资者预期港股将见技术性反弹。上周五恒指牛证街货重货区为收回价26200至26299点,而熊证街货重货区为收回价27400至27499点。

石药(01093)上周五最多泻超过12%,收市跌9.7%,报17.82元,是当日表现最差蓝筹。股份在成交急增下失50天线,14日RSI跌至35的接近超卖水平,并在当日录逾2.6亿元北水净沽出。内地公布新版医保药品名单,多种药品价格下降六成以上,另有券商料石药旗下一款热销药品或被纳入名单,有降价压力。石药今早跌势未止,跌超过2%,失守17.5元水平,见一个月低位。轮证资金流方面,上周五分别有逾580万元和136万元净流出其好仓和淡仓。

近期多间券商包括中信证券(06030)宣布清理重复帐户,实施一人一户。中信证券上周五报14.54元,跌幅2.5%,失100天线。今早升约2%,高见14.9元水平後,升幅收窄。上周五分别有35万元和1万元净流出其好仓和淡仓。

澳门上月博彩毛收入228.77亿澳门元,按年跌8.5%,不过略好过市场预期。银娱(00027)上周五跌逾2.5%,盘中曾跌穿51元,失50天线。今早升逾1%,向上挑战52元水平,此亦是目前250天线所处的位置。上周五有120万元净流入其好仓,淡仓同日则有逾160万元净流出。

全国携号转网正式全国上线,投资者忧虑客户流走及引发减价战。有券商指中移动(00941)在上季录得客户携号转台流出。中移动股价连日受压,上周五收跌2.1%报59元,盘中曾见58.85元创10年低,4个交易日累跌4.8%。今早高开逾1%,於60元关口遇阻,其後徘徊在59元水平。上周五有逾240万元净流入其好仓,淡仓同日则有26万元净流出。

瑞通相关认股证之选择:

石药轻微价外、中短期购25482,行使价:19.8元,2020年3月到期,实际杠杆:6.6倍

石药价外、中年期沽28344,行使价:14.68元,2020年7月到期,实际杠杆:3.3倍

中证贴价、中短期购27550,行使价:15.19元,2020年3月到期,实际杠杆:7.5倍

银河轻微价外、中短期购24070,行使价:58.8元,2020年4月到期,实际杠杆:8倍

银河轻微价外、中短期沽11016,行使价:46.8元,2020年4月到期,实际杠杆:5.9倍

中移轻微价外、中年期购13317,行使价:63.88元,2020年6月到期,实际杠杆:10.2倍

中移价内、中短期沽22475,行使价:60.88元,2020年3月到期,实际杠杆:9.2倍

阿里轻微价内、长期购13511,行使价:197.8元,2020年11月到期,实际杠杆:3.7倍

阿里贴价、中短期购13507,行使价:208元,2020年5月到期,实际杠杆:5.5倍

瑞通相关牛熊证之选择:

恒指N类牛证58812,收回价及行使价:25820点,杠杆比率:34倍

恒指N类熊证61726,收回价及行使价:26880点,杠杆比率:44.9倍

中证牛证61617,收回价:13.1元,杠杆比率:5.4倍

银河牛证61488,收回价:48.6元,杠杆比率:9.8倍

银河熊证60495,收回价:55.5元,杠杆比率:9.8倍

美团牛证61724,收回价:99.44元,杠杆比率:10.3倍

美团熊证57595,收回价:109.9元,杠杆比率:11.5倍重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account